Evidence map›Paper›PMID 37711643›Full record

ArticleDEN open2024

The new 222-nm far ultraviolet-C lowers bacterial contamination to endoscopists during esophagogastroduodenoscopy.

Yukari Fukutoku, Hidezumi Kikuchi, Kentaro Hoshi, Kouji Narita, Taka Asari, Kuniaki Miyazawa, Yohei Sawada, Shiro Hayamizu, Tetsuya Tatsuta, Shinji Oota and 13 more

Abstract read
In one paragraph

Article in DEN open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yukari FukutokuDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Hidezumi KikuchiDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.ORCID https://orcid.org/0000-0002-5163-9563
Kentaro HoshiDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Kouji NaritaDepartment of Microbiology and Immunology Hirosaki University Graduate School of Medicine Aomori Japan.
Taka AsariDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Kuniaki MiyazawaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Yohei SawadaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Shiro HayamizuDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Tetsuya TatsutaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Shinji OotaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Keisuke HasuiDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Hiroto HiragaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.
Daisuke ChindaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.ORCID https://orcid.org/0000-0003-1690-5923
Tatsuya MikamiDepartment of Preemptive Medicine Hirosaki University Graduate School of Medicine Aomori Japan.
Phawinee SubsomwongDepartment of Microbiology and Immunology Hirosaki University Graduate School of Medicine Aomori Japan.
Krisana AsanoDepartment of Microbiology and Immunology Hirosaki University Graduate School of Medicine Aomori Japan.
Kyosuke YamaneHealthy Life Support Department, Marketing Division, Business Creation Division, Corporate Headquarters Ushio Inc. Tokyo Japan.
Yoshimasa OgawaHealthy Life Support Department, Marketing Division, Business Creation Division, Corporate Headquarters Ushio Inc. Tokyo Japan.
Masahiro SasakiHealthy Life Support Department, Marketing Division, Business Creation Division, Corporate Headquarters Ushio Inc. Tokyo Japan.
Toru KoiHealthy Life Support Department, Marketing Division, Business Creation Division, Corporate Headquarters Ushio Inc. Tokyo Japan.ORCID https://orcid.org/0009-0007-4532-5756
Hiroyuki OhashiHealthy Life Support Department, Marketing Division, Business Creation Division, Corporate Headquarters Ushio Inc. Tokyo Japan.
Akio NakaneDepartment of Biopolymer and Health Science Hirosaki University Graduate School of Medicine Aomori Japan.
Hirotake SakurabaDepartment of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to clarify the disinfectant efficacy of the 222-nm far ultraviolet-C (UV-C) during esophagogastroduodenoscopy using bacterial cultures. Methods: The endoscopists performed esophagogastroduodenoscopy wearing a gown with a tryptic soy agar medium plate on their epigastric region and were divided into two groups: 222-nm far UV-C irradiation (UV group) and non-UV irradiation (non-UV group). As a control group, tryptic soy agar medium plates were placed about 110 cm above the floor. The incidence of bacterial contamination was determined by positive bacterial culture. The cultured bacteria were identified by 16S rRNA sequencing. Additionally, the actual UV exposure dose was measured using the UV-indicator card which changed colors upon exposure to 222 nm far UV-C. Results: The bacterial culture positivity in the UV group (5.03%) was significantly lower than that in the non-UV group (25.76%), Conclusions: The 222-nm far UV-C irradiation reduced bacterial contamination for endoscopists. It can be used with conventional physical coverings to provide more effective infection control.

Indexed as

bacteriaendoscopyincidenceinfection controlultraviolet rays

Identifiers

PMID37711643
PMCPMC10497812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.